Symbols

NSRX

Nasus Pharma·AMEX

--(--)

NSRX Profile

Nasus Pharma Ltd.

A clinical-stage specialty pharmaceutical company primarily focused on developing intranasal drugs for treating emergency medical conditions

Industry

Pharmaceutical

Established Date

Listing Date

08/13/2025

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.nasuspharma.com

Security Type

Common stock

Office address

Yigal Alon 65 Tel Aviv Israel 6744317

Business

Introduction

Nasus Pharma Ltd., an Israeli company, was incorporated in Israel in May 2019. They are a clinical stage specialty pharmaceutical company focused on the development of intranasal medicines for the treatment of emergency medical conditions. They are developing a unique PBI technology with a dedicated product portfolio to address acute medical conditions and public health threats.